Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

BUY
$31.71 - $43.0 $108,892 - $147,662
3,434 New
3,434 $127,000
Q1 2022

Apr 12, 2022

SELL
$29.88 - $37.04 $112,408 - $139,344
-3,762 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$25.61 - $35.1 $96,344 - $132,046
3,762 New
3,762 $114,000
Q3 2021

Oct 18, 2021

SELL
$33.54 - $40.55 $18,480 - $22,343
-551 Closed
0 $0
Q2 2021

Jul 16, 2021

BUY
$34.54 - $47.25 $19,031 - $26,034
551 New
551 $22,000
Q4 2020

Jan 11, 2021

SELL
$45.3 - $60.27 $161,177 - $214,440
-3,558 Closed
0 $0
Q3 2020

Oct 23, 2020

BUY
$47.45 - $62.95 $168,827 - $223,976
3,558 New
3,558 $169,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.